Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Priority to DO2009000069ApriorityCriticalpatent/DOP2009000069A/en
Publication of DOP2009000069ApublicationCriticalpatent/DOP2009000069A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicinal Preparation
(AREA)
Abstract
Las composiciones farmaceuticas y metodos se proporcionan para el tratamiento y prevencion de enfermedades de perdida osea que incluye osteoposoris en un mamÃfero.Pharmaceutical compositions and methods are provided for the treatment and prevention of bone loss diseases that include osteoposoris in a mammal.
DO2009000069A2009-04-072009-04-07
PTH PEGILATED AS MODULATORS OF THE PTH RECEIVER AND USES OF THE SAME
DOP2009000069A
(en)
Compounds derived from (4-phenylimidazol-2-yl) ethylamine, such as sodium channel modulators; pharmaceutical composition that includes them; and its use in the treatment of pain.